References
- Thakkar FMV, Soni T, Gohel M. Supercritical fluid technology: a promising approach to enhance the drug solubility. J Pharm Sci Res 2009;1:1–14
- Vo CL-N, Park C, Lee B-J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm 2013;85:799–813
- Chiou WL, Riegelman S. Preparation and dissolution characteristics of several fast release solid dispersions of griseofulvin. J Pharm Sci 1969;58:1505–10
- Gurunath S, Pradeep Kumar S, Basavaraj NK, Patil PA. Amorphous solid dispersion method for improving oral bioavailability of poorly water-soluble drugs. J Pharm Res 2013;6:476–80
- Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–75
- Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107–17
- Deng W, Majumdar S, Singh A, et al. Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion. Drug Dev Ind Pharm 2013;39:290–8
- Chokshi RJ, Sandhu HK, Iyer RM, et al. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution. J Pharm Sci 2005;94:2463–74
- Terife G, Wang P, Faridi N, Gogos CG. Hot melt mixing and foaming of soluplus® and indomethacin. Polym Eng Sci 2012;52:1629–39
- Repka MA, Battu SK, Upadhye SB, et al. Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm 2007;33:1043–57
- He H, Yang R, Tang X. In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm 2010;36:681–7
- Crowley MM, Zhang F, Repka MA, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007;33:909–26
- Arwidsson H, Hjelstuen O, Ingason D, Graffner C. Properties of ethyl cellulose films for extended release. II: influence of plasticizer content and coalescence conditions when using aqueous dispersions. Acta Pharm Nordica 1991;3:65–70
- Elkovitch MD, Tomasko DL. Effect of supercritical carbon dioxide on morphology development during polymer blending. Polym Eng Sci 2000;40:1850–61
- Medina-Gonzalez Y, Camy S, Condoret J-S. Cellulosic materials as biopolymers and supercritical CO2 as a green process: chemistry and applications. Int J Sustainable Eng 2012;5:47–65
- Subramaniam B, Rajewski RA, Snavely K. Pharmaceutical processing with supercritical carbon dioxide. J Pharm Sci 1997;86:885–90
- Rizvi S, Mulvaney S, Sokhey A. The combined application of supercritical fluid and extrusion technology. Trends Food Sci Technol 1995;6:232–40
- Kikic I, Vecchione F, Alessi P, et al. Polymer plasticization using supercritical carbon dioxide: experiment and modeling. Ind Eng Chem Res 2003;42:3022–9
- Verreck G, Decorte A, Heymans K, et al. The effect of pressurized carbon dioxide as a temporary plasticizer and foaming agent on the hot stage extrusion process and extrudate properties of solid dispersions of itraconazole with PVP-VA 64. Eur J Pharm Sci 2005;26:349–58
- Verreck G, Decorte A, Heymans K, et al. Hot stage extrusion of p-amino salicylic acid with EC using CO2 as a temporary plasticizer. Int J Pharm 2006;327:45–50
- Verreck G, Decorte A, Heymans K, et al. The effect of supercritical CO2 as a reversible plasticizer and foaming agent on the hot stage extrusion of itraconazole with EC 20cps. J Supercrit Fluids 2007;40:153–62
- Verreck G, Decorte A, Li H, et al. The effect of pressurized carbon dioxide as a plasticizer and foaming agent on the hot melt extrusion process and extrudate properties of pharmaceutical polymers. J Supercrit Fluids 2006;38:383–91
- Lyons JG, Hallinan M, Kennedy JE, et al. Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process. Int J Pharm 2007;329:62–71
- Sauceau M, Fages J, Common A, et al. New challenges in polymer foaming: a review of extrusion processes assisted by supercritical carbon dioxide. Prog Polym Sci 2011;36:749–66
- Nalawade SP, Picchioni F, Janssen L. Supercritical carbon dioxide as a green solvent for processing polymer melts: processing aspects and applications. Prog Polym Sci 2006;31:19–43
- Ashland Specialty Ingredient, Klucel™ hydroxypropylcellulose physical and chemical properties. 2012, 4
- Repka MA, Gerding TG, Repka SL, McGinity JW. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev Ind Pharm 1999;25:625–33
- Vueba M, Batista de Carvalho L, Veiga F, et al. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur J Pharm Biopharm 2004;58:51–9
- Tiţa D, Fuliaş A, Tiţa B. Thermal stability of ketoprofen – active substance and tablets. J Therm Anal Calorim 2011;105:501–8
- Mohammed NN, Majumdar S, Singh A, et al. Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology. AAPS PharmSciTech 2012;13:1158–69
- Crowley MM, Fredersdorf A, Schroeder B, et al. The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur J Pharm Sci 2004;22:409–18
- http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm
- Jeong H, Toledo R. Twin-screw extrusion at low temperature with carbon dioxide injection to assist expansion: extrudate characteristics. J Food Eng 2004;63:425–32
- Sprunk A, Page S, Kleinebudde P. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug. Int J Pharm 2013;455:189–96
- Andrews GP, Abu-Diak O, Kusmanto F, et al. Physicochemical characterization and drug release properties of celecoxib hot melt extruded glass solutions. J Pharm Pharmacol 2010;62:1580–90
- Ahern RJ, Crean AM, Ryan KB. The influence of supercritical carbon dioxide (SC-CO2) processing conditions on drug loading and physicochemical properties. Int J Pharm 2012;439:92–9